Number of the records: 1
New DHA derivaties and their use as medicaments
- 1.
SYSNO ASEP 0335327 Document Type P - Patent R&D Document Type Patent or other outcome protected by special legislation Title New DHA derivaties and their use as medicaments Title Nové deriváty DHA a jejich léčebné využití Author(s) Bryhn, M. (NO)
Kopecký, Jan (FGU-C) RID, ORCID
Holmeide, A.K. (NO)Year of issue 2009 Possible third party use of the result A - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence Royalty requested A - Poskytovatel licence požaduje licenční poplatek Patent no. or utility model no. or industrial design no. US 7,550,613 B2 Date of the patent acceptance 23.06.2009 Name of the patent owner Pronova BioPharma Norge AS Current use A - Pouze udělený (dosud nevyužívaný) patent nebo patent využívaný jeho vlastníkem Language eng - English Country US - United States Keywords DHA ; diabetes type 2 Subject RIV FB - Endocrinology, Diabetology, Metabolism, Nutrition R&D Projects GA303/08/0664 GA ČR - Czech Science Foundation (CSF) 1M0520 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) GA303/07/0708 GA ČR - Czech Science Foundation (CSF) OC08007 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) OC08008 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) CEZ AV0Z50110509 - FGU-C (2005-2011) Annotation New chemicals derivatives of docosahexaenoic acid have been developed. The derivatives can reduce adipose tissue inflammation and insulin resistance in mice fed high-fat diet. The derivatives could be used as medicaments to treat insulin resistance in diabetic patients Workplace Institute of Physiology Contact Lucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400 Year of Publishing 2010
Number of the records: 1